Immunome Inc (IMNM) — Cash Flow Reinvestment Rate
Latest as of March 2023:
0.01x
Immunome Inc (IMNM) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $212.00K (capex $106.00K plus investments $-106.00K) from operating cash flow of $24.17 Million. See Immunome Inc (IMNM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$212.00K
Capex + Investments
Operating Cash Flow
$24.17 Million
USD
Capital Expenditures
$106.00K
USD
Annual Cash Flow Reinvestment Rate for Immunome Inc (None–None)
Year-by-year capital reinvestment analysis for Immunome Inc. See IMNM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow